Working with Pseudomonas oleovorans in a production bioreactor is nothing like the textbook version
I spent three solid months trying to get consistent surfactin yields out of a batch culture before I figured out what was actually going wrong. The problem wasn't the strain, it wasn't the media formulation, and it definitely wasn't the aeration rate. It was pH drift combined with a silent phase transition in the growth curve that most papers gloss over entirely. Once I mapped it properly, the whole process went from a rolling gamble to something you could reliably scale. That's the thing about Pseudomonas oleovorans — it behaves well on paper and poorly in practice unless you know exactly which knobs to turn. Pseudomonas oleovorans is a Gram-negative, rod-shaped bacterium found widely in soil and water environments. It's notable for its metabolic versatility, particularly its ability to degrade hydrocarbons and produce biosurfactants like rhamnolipids under certain conditions. In biotech contexts, it's been studied for environmental remediation, biofuel production, and more recently for its potential in sustainable chemical manufacturing. The organism is non-pathogenic to humans, which makes it relatively straightforward to handle compared to other Pseudomonas species — though that doesn't mean it's easy to work with. The strain I work with, which is ATCC 8062, grows best at 30°C on LB or minimal media supplemented with glucose or glycerol as a carbon source. Doubling time under optimal conditions is roughly 25 to 30 minutes in exponential phase. That sounds fast until you try to maintain that in a 5-liter bioreactor running on a carbon-limited feed, and then the reality hits pretty quickly.
What actually makes this organism useful in practice
The primary application people come here for is biosurfactant production. Rhamnolipids from P. oleovorans are effective emulsifiers, and they biodegrade far more readily than synthetic alternatives. That matters in industries where regulatory pressure around persistent surfactants is mounting. But here's what the promotional literature won't tell you: yields drop off sharply if you push the dissolved oxygen below 20% saturation. Below that threshold, the cells shift metabolism toward storage compounds instead of surfactant, and you're essentially growing biomass for nothing. I run fed-batch processes with glycerol as the primary carbon source at about 2% w/v initially, then switch to a controlled glucose feed once the glycerol is depleted. The feed rate is set to keep the specific growth rate around 0.15 to 0.2 per hour. That's the range where rhamnolipid synthesis stays elevated without triggering overflow metabolism. If you go faster than that, you get acetate accumulation, and acetate at levels above 2 g/L will stall production entirely. I've lost three separate batches to this before I started monitoring it inline with a simple HPLC check every two hours. The other major application is bioremediation. This organism can degrade alkanes from C10 to C18 quite efficiently, and it's been used in soil washing operations for petroleum-contaminated sites. The limitation there is temperature sensitivity — performance drops significantly below 15°C, which narrows its usefulness in colder climates without supplemental heating or acclimation periods.
Setting up a reliable production workflow
If you're working at lab scale, start with a glycerol stock. Streak onto LB agar plates with 1.5% agar and incubate at 30°C for 24 to 48 hours. Colonies should be cream-colored, slightly raised, and have that characteristic Pseudomonas margin. Pick a single colony into 5 mL of LB and grow overnight at 200 rpm. That's your starter culture. For production media, I use a minimal salts base: 10 g/L (NH)SO, 3 g/L KHPO, 1.5 g/L KHPO, 0.5 g/L NaCl, 0.1 g/L MgSO·7HO, and 0.01 g/L FeSO·7HO. Add your carbon source to taste — glycerol for initial yield optimization, glucose if you're doing long-term fed-batch runs. Filter-sterilize the carbon source separately and add it to the autoclaved salts base after cooling to avoid Maillard reactions that darken the medium and chelate metals. Inoculate at 2% v/v and grow at 30°C with aeration at 1 vvm and agitation at 300 rpm. Monitor optical density at 600 nm. When you hit an OD of around 8 to 10, that's typically when rhamnolipid production ramps up significantly in batch mode. Harvest the supernatant by centrifugation at 8,000 × g for 15 minutes, then extract the biosurfactant with acidified butanol at pH 2.0. The rhamnolipids partition into the organic phase while proteins and most cellular debris stay in the aqueous layer. Evaporate the butanol under reduced pressure and you're left with a crude biosurfactant concentrate.
Get the Full Details
Purity can be further improved through ion-exchange chromatography if you need it for formulation work. A single pass through a DEAE-Sepharose column at pH 7.5 typically gets you above 70% purity, which is sufficient for most application testing.
The edge case that nearly cost me six weeks
There's a specific problem that almost nobody mentions in the published protocols. When you shift from glycerol to glucose feeding in a fed-batch process, the cells undergo a lag phase of about 90 to 120 minutes during which rhamnolipid production drops to near-zero. If you're running a continuous production cycle and not accounting for this, you lose productivity in that window without realizing it. I caught it by accidentally plotting rhamnolipid concentration against time instead of against biomass, which revealed a flat period that coincided exactly with the carbon source switch. The workaround I ended up using is a co-feed strategy. Instead of switching cleanly from glycerol to glucose, I maintain a small glycerol pulse — about 0.5 g/L — alongside the glucose feed throughout the production phase. This keeps the cells in a steady metabolic state without significantly diluting the product. The tradeoff is slightly lower volumetric productivity per liter, but the consistency across batches is dramatically better. Over a 200-liter scale operation, that consistency is worth more than the marginal yield loss.
Common pitfalls and what to do instead
Contamination is more likely than you think. P. oleovorans grows relatively slowly compared to many environmental contaminants, and in minimal media without antibiotics, fast-growing Gram-positives can overtake it within 12 hours. I now always include 50 mg/L of cycloheximide in the media to suppress fungal contamination, and I run a parallel plate with no cycloheximide as a control to make sure it's not affecting my strain. It doesn't affect the growth or production, but you need to verify that for your own isolate. Strain stability is a real issue. Passaging P. oleovorans more than 10 times on standard LB agar without selection pressure leads to visible colony morphology changes and a measurable drop in production capability. I keep a master stock at -80°C in 20% glycerol and only make working stocks from that. Even then, I re-verify production titer every 5 passages against the master. The drop-off is gradual enough that you won't notice it until you're already halfway through a week-long fermentation. pH management is not optional. The organism prefers a pH around 7.0, but during active growth the pH will naturally drop to about 6.2 due to organic acid production. If you don't control it, the pH can fall to 5.5 or lower, which severely inhibits rhamnolipid synthesis. I use 2M NHOH for pH adjustment during fed-batch runs. It serves double duty as both a pH controller and a nitrogen supplement. Just be aware that adding concentrated ammonia raises the ionic strength of the medium, which can affect downstream extraction efficiency if you're not accounting for it.
When this organism simply isn't the right choice
P. oleovorans has clear limitations that make it unsuitable for certain applications. If you're looking at thermophilic processes — anything above 40°C — this organism won't work and you'd be better off considering P. putida or a Bacillus species depending on your target product. If you need extremely high surfactant titers in a compact footprint, P. aeruginosa PAO1-based systems can achieve higher volumetric productivity, though the biosafety implications are significant and may disqualify it for food-grade or pharmaceutical applications. For those cases, P. oleovorans is actually the safer bet despite the lower yields. Another scenario where it fails is high-salinity environments. Growth is inhibited above 3% NaCl, which rules it out for marine bioremediation applications without prior adaptation. I tried adapting a strain to 4% NaCl over four months of serial transfer and never got stable growth, so I moved on to Halomonas species, which are naturally halotolerant and actually produce their own compatible solutes.
Resources and where to get started
The type strain is available from the American Type Culture Collection as ATCC 8062. Various research groups have made genome-sequenced derivatives available through Addgene and similar repositories, but the base strain is a solid starting point for most applications. If you're planning a production-scale operation, I'd strongly recommend sequencing your working stock against the published genome before committing resources — even ATCC strains can accumulate mutations during shipping and storage. For protocol details, the methods described by Castano et al. in their 2016 paper on rhamnolipid optimization from P. oleovorans remains one of the more reliable references, though you'll need to adapt the fed-batch parameters for your own bioreactor setup. There's also decent coverage in the recent reviews by Bandini and Vega around 2023 on industrial biosurfactant production, though those tend to emphasize P. aeruginosa. The practical differences between the two organisms in terms of downstream processing are worth understanding before you commit to one or the other.
